The Supervisory Board of Biotest AG, in its meeting appointed Dr. Michael Ramroth as Chairman of the Board of Management (CEO) effective May 1, 2019. He will take over the role as CEO from Dr. Bernhard Ehmer (64) whose appointment will then end after four and a half years for reasons of age. Dr. Ramroth has been a member of the Board of Management of Biotest AG since 2004. Besides Dr. Michael Ramroth as CEO, Dr. Georg Floss will continue to be a member of the Board of Management of Biotest as COO. Dr. Floss will assume additional responsibilities starting May 1, 2019.